Loading…

Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells

Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascu...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Heart and circulatory physiology 2006-01, Vol.290 (1), p.H30-H36
Main Authors: Rodriguez, Jorge A, De la Cerda, Paula, Collyer, Eileen, Decap, Valerie, Vio, Carlos P, Velarde, Victoria
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23
cites cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23
container_end_page H36
container_issue 1
container_start_page H30
container_title American journal of physiology. Heart and circulatory physiology
container_volume 290
creator Rodriguez, Jorge A
De la Cerda, Paula
Collyer, Eileen
Decap, Valerie
Vio, Carlos P
Velarde, Victoria
description Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2. atherosclerosis; signal transduction; antioxidants Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )
doi_str_mv 10.1152/ajpheart.00349.2005
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_16143655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67588204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EgvL4AiSUFbsUP2InWaIKKBISG1hbjjNpXJw42AmQvyelpaxYWRqfc2d0EbokeE4Ipzdq3dWgfD_HmCX5nGLMD9Bs-qEx4Sw_RDPMBIsFYfwEnYawxhORCnaMToggCROcz9DzYtTWua9xBa0KENPItOWge-PaqBijwqtyfDOtaad5pJzvjY4-VNCDVT4KjXN9HTVD0BYiDdaGc3RUKRvgYveeodf7u5fFMn56fnhc3D7FOuFpH1elwkIRKLMsL1KsBNcJZBWpuGAZz3gOGlNc5LrQWIg0p5wryAASJXRaAWVn6Hqb23n3PkDoZWPC5gLVghuCFCnPMoqTCWRbUHsXgodKdt40yo-SYLnpUf72KH96lJseJ-tqFz8UDZR_zq64Cci3QG1W9afxILt6DMZZtxrl_WDtC3z1-2iaT7vkkmHZldXkxv-7-2v2DvsGiGyXWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67588204</pqid></control><display><type>article</type><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><source>American Physiological Society Free</source><creator>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</creator><creatorcontrib>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</creatorcontrib><description>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2. atherosclerosis; signal transduction; antioxidants Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00349.2005</identifier><identifier>PMID: 16143655</identifier><language>eng</language><publisher>United States</publisher><subject>Adenylyl Cyclase Inhibitors ; Animals ; Aorta - cytology ; Aorta - drug effects ; Bradykinin - pharmacology ; Bradykinin B2 Receptor Antagonists ; Butadienes - pharmacology ; Cells, Cultured ; Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors ; Cyclooxygenase 2 - biosynthesis ; Dideoxyadenosine - analogs &amp; derivatives ; Dideoxyadenosine - pharmacology ; Enzyme Induction - drug effects ; Imidazoles - pharmacology ; Immunohistochemistry ; Isoquinolines - pharmacology ; Male ; Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors ; Muscle, Smooth, Vascular - cytology ; Muscle, Smooth, Vascular - drug effects ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitriles - pharmacology ; p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors ; Protein Kinase C - antagonists &amp; inhibitors ; Pyridines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptor, Bradykinin B2 - physiology ; Sulfonamides - pharmacology</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2006-01, Vol.290 (1), p.H30-H36</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</citedby><cites>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16143655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodriguez, Jorge A</creatorcontrib><creatorcontrib>De la Cerda, Paula</creatorcontrib><creatorcontrib>Collyer, Eileen</creatorcontrib><creatorcontrib>Decap, Valerie</creatorcontrib><creatorcontrib>Vio, Carlos P</creatorcontrib><creatorcontrib>Velarde, Victoria</creatorcontrib><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2. atherosclerosis; signal transduction; antioxidants Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</description><subject>Adenylyl Cyclase Inhibitors</subject><subject>Animals</subject><subject>Aorta - cytology</subject><subject>Aorta - drug effects</subject><subject>Bradykinin - pharmacology</subject><subject>Bradykinin B2 Receptor Antagonists</subject><subject>Butadienes - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</subject><subject>Cyclooxygenase 2 - biosynthesis</subject><subject>Dideoxyadenosine - analogs &amp; derivatives</subject><subject>Dideoxyadenosine - pharmacology</subject><subject>Enzyme Induction - drug effects</subject><subject>Imidazoles - pharmacology</subject><subject>Immunohistochemistry</subject><subject>Isoquinolines - pharmacology</subject><subject>Male</subject><subject>Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors</subject><subject>Muscle, Smooth, Vascular - cytology</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitriles - pharmacology</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</subject><subject>Protein Kinase C - antagonists &amp; inhibitors</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Bradykinin B2 - physiology</subject><subject>Sulfonamides - pharmacology</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOwzAQRS0EgvL4AiSUFbsUP2InWaIKKBISG1hbjjNpXJw42AmQvyelpaxYWRqfc2d0EbokeE4Ipzdq3dWgfD_HmCX5nGLMD9Bs-qEx4Sw_RDPMBIsFYfwEnYawxhORCnaMToggCROcz9DzYtTWua9xBa0KENPItOWge-PaqBijwqtyfDOtaad5pJzvjY4-VNCDVT4KjXN9HTVD0BYiDdaGc3RUKRvgYveeodf7u5fFMn56fnhc3D7FOuFpH1elwkIRKLMsL1KsBNcJZBWpuGAZz3gOGlNc5LrQWIg0p5wryAASJXRaAWVn6Hqb23n3PkDoZWPC5gLVghuCFCnPMoqTCWRbUHsXgodKdt40yo-SYLnpUf72KH96lJseJ-tqFz8UDZR_zq64Cci3QG1W9afxILt6DMZZtxrl_WDtC3z1-2iaT7vkkmHZldXkxv-7-2v2DvsGiGyXWQ</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Rodriguez, Jorge A</creator><creator>De la Cerda, Paula</creator><creator>Collyer, Eileen</creator><creator>Decap, Valerie</creator><creator>Vio, Carlos P</creator><creator>Velarde, Victoria</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><author>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenylyl Cyclase Inhibitors</topic><topic>Animals</topic><topic>Aorta - cytology</topic><topic>Aorta - drug effects</topic><topic>Bradykinin - pharmacology</topic><topic>Bradykinin B2 Receptor Antagonists</topic><topic>Butadienes - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</topic><topic>Cyclooxygenase 2 - biosynthesis</topic><topic>Dideoxyadenosine - analogs &amp; derivatives</topic><topic>Dideoxyadenosine - pharmacology</topic><topic>Enzyme Induction - drug effects</topic><topic>Imidazoles - pharmacology</topic><topic>Immunohistochemistry</topic><topic>Isoquinolines - pharmacology</topic><topic>Male</topic><topic>Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors</topic><topic>Muscle, Smooth, Vascular - cytology</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitriles - pharmacology</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</topic><topic>Protein Kinase C - antagonists &amp; inhibitors</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Bradykinin B2 - physiology</topic><topic>Sulfonamides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez, Jorge A</creatorcontrib><creatorcontrib>De la Cerda, Paula</creatorcontrib><creatorcontrib>Collyer, Eileen</creatorcontrib><creatorcontrib>Decap, Valerie</creatorcontrib><creatorcontrib>Vio, Carlos P</creatorcontrib><creatorcontrib>Velarde, Victoria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez, Jorge A</au><au>De la Cerda, Paula</au><au>Collyer, Eileen</au><au>Decap, Valerie</au><au>Vio, Carlos P</au><au>Velarde, Victoria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>290</volume><issue>1</issue><spage>H30</spage><epage>H36</epage><pages>H30-H36</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2. atherosclerosis; signal transduction; antioxidants Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</abstract><cop>United States</cop><pmid>16143655</pmid><doi>10.1152/ajpheart.00349.2005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2006-01, Vol.290 (1), p.H30-H36
issn 0363-6135
1522-1539
language eng
recordid cdi_pubmed_primary_16143655
source American Physiological Society Free
subjects Adenylyl Cyclase Inhibitors
Animals
Aorta - cytology
Aorta - drug effects
Bradykinin - pharmacology
Bradykinin B2 Receptor Antagonists
Butadienes - pharmacology
Cells, Cultured
Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors
Cyclooxygenase 2 - biosynthesis
Dideoxyadenosine - analogs & derivatives
Dideoxyadenosine - pharmacology
Enzyme Induction - drug effects
Imidazoles - pharmacology
Immunohistochemistry
Isoquinolines - pharmacology
Male
Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors
Muscle, Smooth, Vascular - cytology
Muscle, Smooth, Vascular - drug effects
NG-Nitroarginine Methyl Ester - pharmacology
Nitriles - pharmacology
p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors
Protein Kinase C - antagonists & inhibitors
Pyridines - pharmacology
Rats
Rats, Sprague-Dawley
Receptor, Bradykinin B2 - physiology
Sulfonamides - pharmacology
title Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A17%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclooxygenase-2%20induction%20by%20bradykinin%20in%20aortic%20vascular%20smooth%20muscle%20cells&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Rodriguez,%20Jorge%20A&rft.date=2006-01-01&rft.volume=290&rft.issue=1&rft.spage=H30&rft.epage=H36&rft.pages=H30-H36&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00349.2005&rft_dat=%3Cproquest_pubme%3E67588204%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67588204&rft_id=info:pmid/16143655&rfr_iscdi=true